AU766908B2 - Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis - Google Patents

Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis Download PDF

Info

Publication number
AU766908B2
AU766908B2 AU14142/99A AU1414299A AU766908B2 AU 766908 B2 AU766908 B2 AU 766908B2 AU 14142/99 A AU14142/99 A AU 14142/99A AU 1414299 A AU1414299 A AU 1414299A AU 766908 B2 AU766908 B2 AU 766908B2
Authority
AU
Australia
Prior art keywords
patient
arthritis
dione
androstene
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU14142/99A
Other languages
English (en)
Other versions
AU1414299A (en
Inventor
Charles E Weeks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Humanetics Corp
Original Assignee
Humanetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Humanetics Corp filed Critical Humanetics Corp
Publication of AU1414299A publication Critical patent/AU1414299A/en
Application granted granted Critical
Publication of AU766908B2 publication Critical patent/AU766908B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU14142/99A 1997-11-19 1998-11-17 Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis Ceased AU766908B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6619797P 1997-11-19 1997-11-19
US60/066197 1997-11-19
PCT/US1998/024458 WO1999025192A1 (en) 1997-11-19 1998-11-17 USE OF Δ5-ANDROSTENE-3β-OL-7,17-DIONE IN THE TREATMENT OF ARTHRITIS

Publications (2)

Publication Number Publication Date
AU1414299A AU1414299A (en) 1999-06-07
AU766908B2 true AU766908B2 (en) 2003-10-23

Family

ID=22067899

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14142/99A Ceased AU766908B2 (en) 1997-11-19 1998-11-17 Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis

Country Status (4)

Country Link
EP (1) EP1032266A4 (de)
AU (1) AU766908B2 (de)
CA (1) CA2311471A1 (de)
WO (1) WO1999025192A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043737A1 (en) * 2000-11-30 2002-06-06 Humanetics Corporation Treatment of chronic fatigue syndrome and fibromyalgia syndrome
US6399085B1 (en) 2001-03-05 2002-06-04 Humanetics Corporation Method of moisturizing the skin by the topical application of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof
US6399084B1 (en) 2001-03-05 2002-06-04 Humanetics Corporation Method for diminishing wrinkles and fine lines of the skin by the topical application of Δ5-androstene-3β-ol-7, 17 dione and metabolizable precursors thereof
US6465446B1 (en) 2001-03-12 2002-10-15 John C. Dykstra Treatment of dermatitis by the topical application of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3107256A (en) * 1961-09-20 1963-10-15 Chemetron Corp 16-trifluoroacetyl derivatives of 5-androsten-3beta-ol-17-one
US4628052A (en) * 1985-05-28 1986-12-09 Peat Raymond F Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
US4812447A (en) * 1985-10-22 1989-03-14 City Of Hope Method for the treatment of nervous system degeneration
US5292730A (en) * 1990-08-29 1994-03-08 Humanetics Corporation Modulation of immune system with Δ5-androstenes
JPH09151197A (ja) * 1995-11-29 1997-06-10 L T T Kenkyusho:Kk 自己免疫疾患治療薬

Also Published As

Publication number Publication date
CA2311471A1 (en) 1999-05-27
AU1414299A (en) 1999-06-07
EP1032266A4 (de) 2003-07-16
EP1032266A1 (de) 2000-09-06
WO1999025192A1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
AU738136B2 (en) Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of lupus erythematosus
US5292730A (en) Modulation of immune system with Δ5-androstenes
US5585371A (en) Treatment of immune system with Δ5-androstenes
KENYON The effect of testosterone propionate on the genitalia, prostate, secondary sex characters, and body weight in eunuchoidism
US5641766A (en) UP-regulation of immune system with Δ 5-Androstenes
US5885977A (en) Use of Δ5 androstenes in the treatment of HIV wasting syndrome
AU766908B2 (en) Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis
US6794374B1 (en) Use of Δ5-androstene-3β-OL7,17-dione in the treatment of arthritis
WO2020143744A1 (en) New formulations containing leukotriene receptor antagonists
KR20060011783A (ko) 데하이드로에피안드로스테론 스테로이드 및항-무스카린제와 더불어 호흡기 및 폐 질환을 치료하기위한 조성물, 제제 및 키트
EP1123100B1 (de) Gedächnissverbesserung durch verabreichung von delta-5-androsten-3-beta-ol-7,17-dion und 3-beta-estern desselben
JP4942905B2 (ja) 神経保護活性を有する７−ヒドロキシエピアンドロステロン
WO2002024205A1 (en) TREATMENT OF INFLAMMATORY BOWEL DISEASE BY THE ADMINISTRATION OF Δ5-ANDROSTENE-3β-OL-7,17 DIONE AND METABOLIZABLE PRECURSORS THEREOF
US7553829B2 (en) Treatment of chronic fatigue syndrome and fibromyalgia syndrome
HENDERSON et al. Androgens and Renal Function. Effect of Testosterone Propionate in Uremia due to Cholera
AU777497B2 (en) Use of delta5-androstene-3beta-OL-7, 17-dione in the treatment of lupus erythematosus
US7199116B2 (en) Method of modulating the basal metabolic rate of a dieting mammal by administration of a metabolic modulating agent to the dieting mammal
AU4948497A (en) A method for lowering plasma levels of lipoprotein(a)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)